Over 75 Emerging Biotech Firms Adopting Veeva Basics for Efficiency Boost Veeva Basics has become essential for over 75 biotech companies seeking to enhance efficiency in clinical, regulatory, and quality areas. Find out more!

Over 75 Emerging Biotech Firms Adopting Veeva Basics for Efficiency Boost #USA #Veeva_Systems #Barcelona #Biotech_Industry #Veeva_Basics

Mark Hensley Joins Heron Therapeutics as Chief Operating Officer to Drive Next Growth Phase Heron Therapeutics has appointed Mark Hensley as Chief Operating Officer, bringing over fifteen years of pharmaceutical industry experience to boost the company's growth initiatives.

Mark Hensley Joins Heron Therapeutics as Chief Operating Officer to Drive Next Growth Phase #United_States #CARY #Heron_Therapeutics #Biotech_Industry #Mark_Hensley

Greg Kunst Recognized as Pinnacle Professional Member in Biotech Excellence Greg Kunst has been acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for his innovative contributions in the biotech industry.

Greg Kunst Recognized as Pinnacle Professional Member in Biotech Excellence #USA #Seattle #Biotech_Industry #Greg_Kunst #Aurion_Biotech

Veteran Pharma Executive Ashish Patel, PhD, Joins Nanoscope as New Senior Vice President Nanoscope Therapeutics welcomes PhD Ashish Patel as Senior Vice President, Sales and Marketing, to enhance its vision restoration initiatives.

Veteran Pharma Executive Ashish Patel, PhD, Joins Nanoscope as New Senior Vice President #USA #Dallas #Nanoscope_Therapeutics #Biotech_Industry #Ashish_Patel

Ben Krol Joins MAGic BioProcessing as Director for North America East MAGic BioProcessing is excited to announce that Ben Krol has joined as the new Director of Sales and Business Development for North America East, enhancing their team with his expertise.

Ben Krol Joins MAGic BioProcessing as Director for North America East #USA #Boston #Biotech_Industry #Ben_Krol #MAGic_BioProcessing

Spyre Therapeutics Grants Stock Options to Non-Executive Employees as Incentive Awards Spyre Therapeutics announces the approval of stock options to three non-executive employees under its 2018 Equity Inducement Plan, enhancing recruitment efforts.

Spyre Therapeutics Grants Stock Options to Non-Executive Employees as Incentive Awards #United_States #stock_options #Spyre_Therapeutics #Waltham #Biotech_Industry

Aktis Oncology Welcomes Mary Thistle to Board Amid Strategic Growth Phase Mary Thistle has been appointed to Aktis Oncology's Board of Directors, leveraging her extensive biotech experience as the company aims to enhance its growth in targeted radiopharmaceuticals.

Aktis Oncology Welcomes Mary Thistle to Board Amid Strategic Growth Phase #United_States #Boston #Aktis_Oncology #Mary_Thistle #Biotech_Industry